Ruth Geiss‐Friedlander

Also affiliated with Universitätsmedizin Göttingen

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19”.

Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.21.392753

N/A

0DataRank · unranked

12 citations

Heeyoung Kim, John C. Widen, Brett M. Babin, Ouma Onguka, S. Lovell +10 more

Chemoproteomics‐Enabled Identification of 4‐Oxo‐β‐Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9

Angewandte Chemie International Edition(2022)10.1002/anie.202210498

N/A

0DataRank · unranked

13 citations

B. Ross, Lorenz Fehr, Oguz Bolgi, Svenja Wöhrle, Kenneth M. Lum +13 more

Chemoproteomik‐basierte Identifikation von 4‐Oxo‐β‐lactamen als Inhibitoren der Dipeptidylpeptidasen 8 und 9

Angewandte Chemie(2022)10.1002/ange.202210498

N/A

0DataRank · unranked

1 citations

B. Ross, Lorenz Fehr, Oguz Bolgi, Svenja Wöhrle, Kenneth M. Lum +13 more